Clinical Trial Update: Tissue Inhibitor of Metalloproteinases 2 Level in Patients Undergoing Cardiac Surgery [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating Tissue Inhibitor of Metalloproteinases 2 (TIMP-2) levels in patients undergoing cardiac surgery to assess acute kidney injur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Snippet

Sponsor: Wuhan University | Conditions: Acute Kidney Injury, Extracorporeal Circulation; Complications | Phase 1, Phase 2 | Status: COMPLETED